These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
114 related items for PubMed ID: 30824390
1. Impact of RAGE polymorphisms on urothelial cell carcinoma clinicopathologic characteristics and long-term survival. Hung SC, Wang SS, Li JR, Chen CS, Lin CY, Chang LW, Chiu KY, Cheng CL, Ou YC, Yang SF. Urol Oncol; 2019 Sep; 37(9):573.e9-573.e17. PubMed ID: 30824390 [Abstract] [Full Text] [Related]
2. RAGE gene polymorphism and environmental factor in the risk of oral cancer. Su S, Chien M, Lin C, Chen M, Yang S. J Dent Res; 2015 Mar; 94(3):403-11. PubMed ID: 25582438 [Abstract] [Full Text] [Related]
3. Polymorphisms in the receptor for advanced glycation end-products (RAGE) gene and circulating RAGE levels as a susceptibility factor for non-alcoholic steatohepatitis (NASH). Mehta R, Shaw G, Masschelin P, Felix S, Otgonsuren M, Baranova A, Goodman Z, Younossi Z. PLoS One; 2018 Mar; 13(6):e0199294. PubMed ID: 29928018 [Abstract] [Full Text] [Related]
4. Effects of RAGE Gene Polymorphisms on the Risk and Progression of Hepatocellular Carcinoma. Su SC, Hsieh MJ, Chou YE, Fan WL, Yeh CB, Yang SF. Medicine (Baltimore); 2015 Aug; 94(34):e1396. PubMed ID: 26313784 [Abstract] [Full Text] [Related]
5. Impacts of CA9 gene polymorphisms on urothelial cell carcinoma susceptibility and clinicopathologic characteristics in Taiwan. Wang SS, Liu YF, Ou YC, Chen CS, Li JR, Yang SF. PLoS One; 2013 Aug; 8(12):e82804. PubMed ID: 24349364 [Abstract] [Full Text] [Related]
6. The promoter polymorphisms of receptor for advanced glycation end products were associated with the susceptibility and progression of sepsis. Shao Y, Shao X, He J, Cai Y, Zhao J, Chen F, Tao H, Yin Z, Tan X, He Y, Lin Y, Li K, Cui L. Clin Genet; 2017 Apr; 91(4):564-575. PubMed ID: 27172264 [Abstract] [Full Text] [Related]
7. Functional genetic variant of WW domain containing oxidoreductase gene associated with urothelial cell carcinoma clinicopathologic characteristics and long-term survival. Hung SC, Chou YE, Li JR, Chen CS, Lin CY, Chang LW, Chiu KY, Cheng CL, Ou YC, Wang SS, Yang SF. Urol Oncol; 2020 Feb; 38(2):41.e1-41.e9. PubMed ID: 31474505 [Abstract] [Full Text] [Related]
8. Impact of Matrix Metalloproteinases 11 Gene Variants on Urothelial Cell Carcinoma Development and Clinical Characteristics. Li CC, Hsieh MJ, Wang SS, Hung SC, Lin CY, Kuo CW, Yang SF, Chou YE. Int J Environ Res Public Health; 2020 Jan 11; 17(2):. PubMed ID: 31940762 [Abstract] [Full Text] [Related]
9. Effect of HMGB1 Polymorphisms on Urothelial Cell Carcinoma Susceptibility and Clinicopathological Characteristics. Hung SC, Wang SS, Li JR, Chen CS, Yang CK, Chiu KY, Cheng CL, Ou YC, Ho HC, Yang SF. Int J Med Sci; 2018 Jan 11; 15(14):1731-1736. PubMed ID: 30588197 [Abstract] [Full Text] [Related]
10. Association of RAGE gene four single nucleotide polymorphisms with the risk, invasion, metastasis and overall survival of gastric cancer in Chinese. Hu D, Liu Q, Lin X, Zhang H, Lin J, Zheng X, Peng F. J Cancer; 2019 Jan 11; 10(2):504-509. PubMed ID: 30719146 [Abstract] [Full Text] [Related]
11. Dopamine receptor D2 genetic variations is associated with the risk and clinicopathological variables of urothelial cell carcinoma in a Taiwanese population. Tung MC, Wen YC, Wang SS, Lin YW, Liu YC, Yang SF, Chien MH. Int J Med Sci; 2018 Jan 11; 15(11):1187-1193. PubMed ID: 30123056 [Abstract] [Full Text] [Related]
12. Effects of Long Noncoding RNA H19 Polymorphisms on Urothelial Cell Carcinoma Development. Yang PJ, Hsieh MJ, Hung TW, Wang SS, Chen SC, Lee MC, Yang SF, Chou YE. Int J Environ Res Public Health; 2019 Apr 12; 16(8):. PubMed ID: 31013794 [Abstract] [Full Text] [Related]
13. Determination of SIRT1 rs12778366, FGFR2 rs2981582, STAT3 rs744166, and RAGE rs1800625 Single Gene Polymorphisms in Patients with Laryngeal Squamous Cell Carcinoma. Uloza V, Tamauskaite T, Vilkeviciute A, Pasvenskaite A, Liutkevicius V, Liutkeviciene R. Dis Markers; 2019 Apr 12; 2019():3907232. PubMed ID: 31781300 [Abstract] [Full Text] [Related]
14. Impact of endothelial nitric oxide synthase polymorphisms on urothelial cell carcinoma development. Tsay MD, Hsieh MJ, Wang SS, Wang WC, Chou YY, Shih CH, Yang SF, Chou YE. Urol Oncol; 2019 Apr 12; 37(4):293.e1-293.e9. PubMed ID: 30611644 [Abstract] [Full Text] [Related]
15. WISP1 genetic variants as predictors of tumor development with urothelial cell carcinoma. Lee HL, Chiou HL, Wang SS, Hung SC, Chou MC, Yang SF, Hsieh MJ, Chou YE. Urol Oncol; 2018 Apr 12; 36(4):160.e15-160.e21. PubMed ID: 29277583 [Abstract] [Full Text] [Related]
16. Genetic predisposition of six well-defined polymorphisms in HMGB1/RAGE pathway to breast cancer in a large Han Chinese population. Yue L, Zhang Q, He L, Zhang M, Dong J, Zhao D, Ma H, Pan H, Zheng L. J Cell Mol Med; 2016 Oct 12; 20(10):1966-73. PubMed ID: 27241711 [Abstract] [Full Text] [Related]
17. The impact of receptor of advanced glycation end-products polymorphisms on prostate cancer progression and clinicopathological characteristics. Chou YE, Hsieh MJ, Wang SS, Lin CY, Chen YY, Ho YC, Yang SF. J Cell Mol Med; 2021 Nov 12; 25(22):10761-10769. PubMed ID: 34708514 [Abstract] [Full Text] [Related]
18. Impact of EZH2 polymorphisms on urothelial cell carcinoma susceptibility and clinicopathologic features. Yu YL, Su KJ, Hsieh MJ, Wang SS, Wang PH, Weng WC, Yang SF. PLoS One; 2014 Nov 12; 9(4):e93635. PubMed ID: 24691023 [Abstract] [Full Text] [Related]
19. The Association Between Variants of Receptor for Advanced Glycation End Products (RAGE) Gene Polymorphisms and Age-Related Macular Degeneration. Banevicius M, Vilkeviciute A, Kriauciuniene L, Liutkeviciene R, Deltuva VP. Med Sci Monit; 2018 Jan 10; 24():190-199. PubMed ID: 29317590 [Abstract] [Full Text] [Related]
20. A multicenter matched case-control analysis on seven polymorphisms from HMGB1 and RAGE genes in predicting hepatocellular carcinoma risk. Wang D, Qi X, Liu F, Yang C, Jiang W, Wei X, Li X, Mi J, Tian G. Oncotarget; 2017 Jul 25; 8(30):50109-50116. PubMed ID: 28187002 [Abstract] [Full Text] [Related] Page: [Next] [New Search]